throbber
Bioinformatics,
`a new
`interdisciplinary
`science, is
`essential to
`managing,
`understanding,
`and harnessing
`clinical benefit
`from new
`genetic data
`
`Centre for
`Integrated Genomic
`Medical Research,
`University of
`Manchester,
`Manchester
`M13 9PT
`Ardeshir Bayat
`MRC fellow
`
`Correspondence to:
`ardeshir.bayat@
`man.ac.uk
`
`BMJ 2002;324:1018–22
`
`Clinical review
`
`Science, medicine, and the future
`Bioinformatics
`Ardeshir Bayat
`
`An unprecedented wealth of biological data has been
`generated by the human genome project and sequenc(cid:173)
`ing projects in other organisms. The huge demand for
`analysis and interpretation of these data is being man(cid:173)
`aged by the evolving science of bioinformatics.
`Bioinformatics is defined as the application of tools of
`computation and analysis to the capture and interpret(cid:173)
`ation of biological data. It is an interdisciplinary field,
`which harnesses computer science, mathematics, phys(cid:173)
`ics, and biology (fig 1). Bioinformatics is essential for
`management of data in modern biology and medicine.
`This paper describes the main tools of the bioinforma(cid:173)
`tician and discusses how they are being used to
`interpret biological data and to further understanding
`of disease. The potential clinical applications of these
`data in drug discovery and development are also
`discussed.
`
`Methods
`
`This article is based on personal experience in
`bioinformatics and on selected articles in recent issues
`of Nature Genetics, Nature Genetics Reviews, Nature Medi(cid:173)
`cine, and Science. Key terms including bioinformatics,
`comparative and functional genomics, proteomics,
`microarray, disease, and medicine were used to search
`for relevant articles in the peer reviewed scientific
`literature.
`
`Bioinformatics and its impact on
`genomics
`
`Last year it was announced that the entire human
`genome had been mapped as a result of the efforts of
`
`Biology
`
`Medicine
`
`Bioinformatics
`
`Maths/physics
`
`Computer science
`
`An additional figure
`appears on
`bmj.com
`
`1018
`
`Fig 1 Interaction of disciplines that have contributed to the
`formation of bioinformatics
`
`Summary points
`
`Bioinformatics is the application of tools of
`computation and analysis to the capture and
`interpretation of biological data
`
`Bioinformatics is essential for management of
`data in modern biology and medicine
`
`The bioinformatics toolbox includes computer
`software programs such as BLAST and Ensembl,
`which depend on the availability of the internet
`
`Analysis of genome sequence data, particularly
`the analysis of the human genome project, is one
`of the main achievements of bioinformatics to
`date
`
`Prospects in the field of bioinformatics include its
`future contribution to functional understanding
`of the human genome, leading to enhanced
`discovery of drug targets and individualised
`therapy
`
`the worldwide human genome project and a private
`genomic company.1 2 However, in recent years, the sci(cid:173)
`entific world has witnessed the completion of whole
`genome sequences of many other organisms. The
`analysis of the emerging genomic sequence data and
`the human genome project is a landmark achievement
`for bioinformatics.
`A novel strategy for random sequencing of the
`whole genome (the so called “shot gun” technique) was
`used to sequence the genome of Haemophilus influenzae
`in 1995.3 This was the very first complete genome of
`any free living organism to be sequenced. Other bacte(cid:173)
`rial genomes, such as those of Mycoplasma genitalium
`and Mycobacterium tuberculosis, were sequenced soon
`after,4 5 and the sequence of the plague bacterium Yers(cid:173)
`inia pestis was recently completed.6 The sequence and
`annotation of the first eukaryotic genome, that of Sac(cid:173)
`charomyces cerevisiae (a yeast),7 was followed by those of
`other eukaryotic species such as Caenorhabtidis elegans
`(a worm),8 Drosophila melanogaster (fruit fly),9 and Arab(cid:173)
`dopsis thaliana (mustard weed)10 (see fig A on bmj.com).
`Sequencing of
`several other
`species,
`including
`
`Petitioner Microsoft Corporation - Ex. 1029, p. 1018
`
`BMJ VOLUME 324 27 APRIL 2002 bmj.com
`
`

`

`Useful bioinformatic websites (available freely
`on the internet)
`• National Center for Biotechnology Information
`(www.ncbi.nlm.nih.gov)—maintains bioinformatic tools
`and databases
`• National Center for Genome Resources
`(www.ncgr.org/)—links scientists to bioinformatics
`solutions by collaborations, data, and software
`development
`• Genbank (www.ncbi.nlm.nih.gov/Genbank)—stores
`and archives DNA sequences from both large scale
`genome projects and individual laboratories
`• Unigene (www.ncbi.nlm.nih.gov/UniGene)—gene
`sequence collection containing data on map location
`of genes in chromosomes
`• European Bioinformatic Institute
`(www.ebi.ac.uk)—centre for research and services in
`bioinformatics; manages databases of biological data
`• Ensembl (www.ensembl.org)—automatic annotation
`database on genomes
`• BioInform (www.bioinform.com)—global
`bioinformatics news service
`• SWISS(cid:173)PROT (www.expasy.org/sprot/)—important
`protein database with sequence data from all
`organisms, which has a high level of annotation
`(includes function, structure, and variations) and is
`minimally redundant (few duplicate copies)
`• International Society for Computational Biology
`(www.iscb.org/)—aims to advance scientific
`understanding of living systems through computation;
`has useful bioinformatic links
`
`zebrafish, pufferfish, mouse, rat, and non(cid:173)human
`primates, are either under way or nearing completion
`by both private and public sequencing initiatives.11 The
`knowledge obtained from these sequence data will
`have considerable implications for our understanding
`of biology and medicine. As a result of comparative
`genomic and proteomic research, we will soon be able
`to not only locate each human gene but also fully
`understand its function.12
`
`Bioinformatic tools
`
`The main tools of a bioinformatician are computer
`software programs and the internet. A fundamental
`activity is sequence analysis of DNA and proteins using
`various programs and databases available on the world
`wide web. Anyone,
`from clinicians
`to molecular
`biologists, with access to the internet and relevant web(cid:173)
`sites can now freely discover the composition of
`biological molecules such as nucleic acids and proteins
`by using basic bioinformatic tools. This does not imply
`that handling and analysis of raw genomic data can
`easily be carried out by all. Bioinformatics is an evolv(cid:173)
`ing discipline, and expert bioinformaticians now use
`complex software programs for retrieving, sorting out,
`analysing, predicting, and storing DNA and protein
`sequence data.
`Large commercial enterprises such as pharmaceu(cid:173)
`tical companies employ bioinformaticians to perform
`and maintain the large scale and complicated bioinfor(cid:173)
`matic needs of
`these industries. With an ever(cid:173)
`increasing need for constant input from bioinformatic
`experts, most biomedical laboratories may soon have
`their own in(cid:173)house bioinformatician. The individual
`
`BMJ VOLUME 324 27 APRIL 2002 bmj.com
`
`Clinical review
`
`researcher, beyond a basic acquisition and analysis of
`simple data, would certainly need external bioinfor(cid:173)
`matic advice for any complex analysis.
`The growth of bioinformatics has been a global
`venture, creating computer networks that have allowed
`easy access to biological data and enabled the develop(cid:173)
`ment of software programs for effortless analysis.
`Multiple international projects aimed at providing
`gene and protein databases are available freely to the
`whole scientific community via the internet.
`
`Bioinformatic analysis
`
`The escalating amount of data from the genome
`projects has necessitated computer databases that fea(cid:173)
`ture rapid assimilation, usable formats and algorithm
`software programs
`for efficient management of
`biological data.13 Because of the diverse nature of
`emerging data, no single comprehensive database
`exists for accessing all this information. However, a
`growing number of databases that contain helpful
`information for clinicians and researchers are avail(cid:173)
`able. Information provided by most of these databases
`is free of charge to academics, although some sites
`require subscription and industrial users pay a licence
`fee for particular sites. Examples range from sites pro(cid:173)
`viding comprehensive descriptions of clinical disor(cid:173)
`ders,
`listing disease susceptibility genetic mutations
`and polymorphisms, to those enabling a search for dis(cid:173)
`ease genes given a DNA sequence (box).
`These databases include both “public” repositories
`of gene data as well as those developed by private com(cid:173)
`panies. The easiest way to identify databases is by
`
`Fig 2 Ensembl website: a genomic data search facility freely available on the internet.
`Ensembl is a joint project between the European Bioinformatic Institute and the Sanger
`Centre, which is capable of automatically tracking the sequenced pieces of the human
`genome and assembling and analysing them to identify genes and other features of interest
`to biomedical researchers
`
`Petitioner Microsoft Corporation - Ex. 1029, p. 1019
`
`1019
`
`

`

`database links and searchable indexes provided by one
`of
`the major public databases. For example,
`the
`National Center
`for Biotechnology
`Information
`(www.ncbi.nlm.nih.gov) provides the Entrez browser,
`which is an integrated database retrieval system that
`allows integration of DNA and protein sequence data(cid:173)
`bases. The European Bioinformatic Institute archives
`gene and protein data from genome studies of all
`organisms, whereas Ensembl produces and maintains
`automatic annotation on eukaryotic genomes (fig 2).
`The quality and reliability of databases vary; certainly
`some of the better known and more established ones,
`such as those above, are superior to others.
`One of the simplest and better known search tools
`is called BLAST (basic local alignment search tool, at
`www.ncbi.nlm.nih.gov/BLAST/). This algorithm soft(cid:173)
`ware is capable of searching databases for genes with
`similar nucleotide structure (fig 3) and allows compari(cid:173)
`son of an unknown DNA or amino acid sequence with
`hundreds or thousands of sequences from human or
`other organisms until a match is found. Databases of
`known sequences are thus used to identify similar
`sequences, which may be homologues of the query
`sequence. Homology implies that sequences may be
`related by divergence from a common ancestor or
`share common functional aspects. When a database is
`searched with a newly determined sequence (the query
`sequence), local alignment occurs between the query
`sequence and any similar sequence in the database.
`The result of the search is sorted in order of priority on
`the basis of maximum similarity. The sequence with the
`highest score in the database of known genes is the
`homologue. If homologues or related molecules exist
`for a query sequence, then a newly discovered protein
`may be modelled and the gene product may be
`predicted without
`the need for further laboratory
`experiments.
`
`Functional genomics
`
`Since the completion of the first draft of the human
`genome,1 2
`the emphasis has been changing from
`genes themselves to gene products. Functional genom(cid:173)
`ics assigns functional relevance to genomic infor(cid:173)
`mation. It is the study of genes, their resulting proteins,
`and the role played by the proteins.
`Analysis and interpretation of biological data con(cid:173)
`siders information not only at the level of the genome
`but at the level of the proteome and the transcriptome
`(fig 4). Proteomics is the analysis of the total amount of
`proteins (proteome) expressed by a cell, and transcrip(cid:173)
`tomics refers to the analysis of the messenger RNA
`transcripts produced by a cell (transcriptome). DNA
`microarray technology determines the expression level
`of genes and includes genotyping and DNA sequenc(cid:173)
`ing. Gene expression arrays allow simultaneous analy(cid:173)
`sis of
`the messenger RNA expression levels of
`thousands of genes in benign and malignant tumours,
`such as keloid and melanoma. Expression profiles clas(cid:173)
`sify
`tumours and provide potential
`therapeutic
`targets.14
`Bioinformatic protein research draws on annotated
`protein and two dimensional electrophoresis data(cid:173)
`bases. After separation, identification, and characterisa(cid:173)
`tion of a protein, the next challenge in bioinformatics is
`the prediction of its structure. Structural biologists also
`
`Petitioner Microsoft Corporation - Ex. 1029, p. 1020
`
`BMJ VOLUME 324 27 APRIL 2002 bmj.com
`
`Clinical review
`
`Fig 3 Web page illustrating freely available BLAST services run by
`the National Center for Biotechnology Information. BLAST (basic local
`alignment search tool) is a set of similarity search programs
`designed to explore all of the available DNA sequence databases
`
`searching for bioinformatic tools and databases in any
`one of the commonly used search engines. Another
`way to identify bioinformatic sources is through
`
`I
`
`...agcttgatattatacgcgcggca
`
`II
`
`III
`
`IV
`
`Genomics
`
`DNA
`
`Makes
`
`Transcriptomics
`
`RNA
`
`Makes
`
`Proteomics
`
`Protein
`
`C o m p l e x i t y
`
`Fig 4 Schematic diagram representing complexity of genomic data processing. Analysis and
`interpretation of biological data considers information at every level from the genome (total
`genetic content) to the proteome (total protein content) and transcriptome (total messenger
`RNA content) of the cell. The images numbered I(cid:173)IV to the right of the diagram represent
`relevant examples of DNA (image I is base pair nucleotides); RNA (image II is a microarray
`showing levels of gene expression); and protein (image III is a structure of a single protein;
`image IV is a two dimensional gel electrophoresis showing separation of all proteins of a
`cell—each spot corresponds to a different protein chain)
`
`1020
`
`

`

`use bioinformatics to handle the vast and complex data
`from x ray crystallography, nuclear magnetic reso(cid:173)
`nance, and electron microscopy investigations to create
`three dimensional models of molecules.15
`
`Other applications of bioinformatics
`
`from analysis of genome sequence data,
`Apart
`bioinformatics is now being used for a vast array of
`other important tasks, including analysis of gene varia(cid:173)
`tion and expression, analysis and prediction of gene
`and protein structure and function, prediction and
`detection of gene regulation networks, simulation envi(cid:173)
`ronments for whole cell modelling, complex modelling
`of gene regulatory dynamics and networks, and
`presentation and analysis of molecular pathways in
`interactions.16
`order
`to understand gene(cid:173)disease
`Although on a smaller scale, simpler bioinformatic
`tasks valuable to the clinical researcher can vary from
`designing primers (short oligonucleotide sequences
`needed for DNA amplification in polymerase chain
`reaction experiments) to predicting the function of
`gene products.
`
`Clinical application of bioinformatics
`
`The clinical applications of bioinformatics can be
`viewed in the immediate, short, and long term. The
`human genome project plans to complete the human
`sequence by 2003, producing a database of all the vari(cid:173)
`ations in sequence that distinguish us all. The project
`could have considerable impact on people living in
`2020—for example, a complete list of human gene
`products may provide new drugs and gene therapy for
`single
`gene
`diseases may
`become
`routine
`(www.ornl.gov/hgmis/medicine/tnty.html).
`Basic bioinformatic tools are already accessed in
`certain clinical situations to aid in diagnosis and treat(cid:173)
`ment plans. For example, PubMed (www.nlm.nih.gov)
`is accessed freely for biomedical
`journals cited in
`Medline, and OMIM (Online Mendelian Inheritance in
`Man at www3.ncbi.nlm.nih.gov/Omim/), a search tool
`for human genes and genetic disorders, is used by cli(cid:173)
`nicians to obtain information on genetic disorders in
`the clinic or hospital setting. An example of the appli(cid:173)
`cation of bioinformatics in new therapeutic advances is
`the development of novel designer targeted drugs such
`as imatinib mesylate (Gleevec), which interferes with
`the abnormal protein made in chronic myeloid
`leukaemia.17
`(Imatinib mesylate was synthesised at
`Novartis Pharmaceuticals by identifying a lead in a
`high throughput screen for tyrosine kinase inhibitors
`and optimising its activity for specific kinases.) The
`ability to identify and target specific genetic markers by
`using bioinformatic tools facilitated the discovery of
`this drug.
`In the short term, as a result of the emerging bioin(cid:173)
`formatic analysis of the human genome project, more
`disease genes will be identified and new drug targets
`will be simultaneously discovered. Bioinformatics will
`serve to identify susceptibility genes and illuminate the
`pathogenic pathways involved in illness, and will there(cid:173)
`fore provide an opportunity for development of
`targeted therapy. Recently, potential targets in cancers
`were identified from gene expression profiles.18
`
`BMJ VOLUME 324 27 APRIL 2002 bmj.com
`
`Clinical review
`
`Additional educational resources
`
`Journals
`• Specific bioinformatic journals exist (for example,
`www.bioinformatics.oupjournals.org), but papers from
`every area of science and medicine involving
`bioinformatic analysis are published in any biomedical
`journal. Examples include:
`• The human genome (special issue). Nature
`2001;409:813(cid:173)933.
`• The human genome (special issue). Science
`2001;5507:1145(cid:173)434.
`• The human genome (special issue). JAMA
`2001;286:2211(cid:173)333.
`• The human genome (special issue). Scientific
`American 2000;283:38(cid:173)57.
`• Luscombe NM, Greenbaum D, Gerstein M. What is
`bioinformatics? Method Inform Med 2001;40:346(cid:173)58.
`• Online Lectures on Bioinformatics
`(www.lectures.molgen.mpg.de/)
`
`Books
`• Mount DW. Bioinformatics: sequence and genome
`analysis. Cold Spring Harbor Laboratory Press, 2001.
`• Baxevanis AD, Ouellette BFF. Bioinformatics: a
`practical guide to the analysis of genes and proteins. 2nd ed.
`John Wiley and Sons, 2001.
`• Lengauer T (Ed). Bioinformatics. Wiley(cid:173)VCH Series,
`2001. (Methods and principles in medicinal chemistry
`series.)
`• Higgins D, Taylor W. Bioinformatics. Oxford
`University Press, 2000. (Practical approach series.)
`• Baldi P, Brunak S. Bioinformatics. 2nd ed. MIT Press,
`2001. (Adaptive computation and machine learning
`series.)
`
`BMJ archive
`• Aitman TJ. DNA microarrays in medical practice.
`BMJ 2001;323:611(cid:173)5.
`• Mathew CG. Postgenomic technologies: hunting the
`genes for common disorders. BMJ 2001;322:1031(cid:173)4.
`• Stewart A, Haites N, Rose P. Online medical genetics
`resources: a UK perspective. BMJ 2001;322:1037(cid:173)9.
`• Savill J. Molecular genetic approaches to
`understanding disease. BMJ 1997;314:126(cid:173)9.
`
`In the longer term, integrative bioinformatic analy(cid:173)
`sis of genomic, pathological, and clinical data in clinical
`trials will reveal potential adverse drug reactions in
`individuals by use of simple genetic tests. Ultimately,
`pharmacogenomics (using genetic information to
`individualise drug treatment) is likely to bring about a
`new age of personalised medicine; patients will carry
`gene cards with their own unique genetic profile for
`certain drugs aimed at individualised therapy and tar(cid:173)
`geted medicine free from side effects.
`
`Future directions
`
`The practice of studying genetic disorders is changing
`from investigation of single genes in isolation to
`discovering cellular networks of genes, understanding
`their complex interactions, and identifying their role in
`disease.19 As a result of this, a whole new age of
`individually tailored medicine will emerge. Bioinfor(cid:173)
`matics will guide and help molecular biologists and
`clinical researchers to capitalise on the advantages
`brought by computational biology.20 The clinical
`
`Petitioner Microsoft Corporation - Ex. 1029, p. 1021
`
`1021
`
`

`

`Clinical review
`
`research teams that will be most successful in the com(cid:173)
`ing decades will be those that can switch effortlessly
`between the laboratory bench, clinical practice, and the
`use of these sophisticated computational tools.
`
`I thank Tessa Richards, Dipak Roy, and Professor Bill Ollier for
`advice on the preparation of this manuscript and Andy Brass for
`providing me with some of the diagrams.
`Funding: Medical Research Council.
`Competing interests: None declared.
`
`1 International Human Genome Sequencing Consortium. Initial sequenc(cid:173)
`ing and analysis of the human genome. Nature 2001;409:860(cid:173)921.
`2 Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The
`sequence of the human genome. Science 2001;291:1304(cid:173)51.
`3 Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlav(cid:173)
`age AR, et al. Whole(cid:173)genome random sequencing and assembly of Hae(cid:173)
`mophilus influenzae Rd. Science 1995;269:496(cid:173)512.
`4 Fraser CM, Gocayne JD, White O, Adams MD, Clayton RA, Fleischmann
`RD, et al. The minimal gene complement of Mycoplasma genitalium.
`Science 1995;270:397(cid:173)403.
`5 Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deci(cid:173)
`phering the biology of Mycobacterium tuberculosis from the complete
`genome sequence. Nature 1998;393:537(cid:173)44.
`6 Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB,
`et al. Genome sequence of Yersinia pestis, the causative agent of plague.
`Nature 2001;413:523(cid:173)27.
`7 Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, et al.
`Life with 6000 genes. Science 1996;274:546.
`
`8 The C. elegans Sequencing Consortium. Genome sequence of the nema(cid:173)
`tode C. elegans: a platform for
`investigating biology. Science
`1998;282:2012(cid:173)8.
`9 Myers EW, Sutton GG, Delcher AL, Dew IM, Fasulo DP, Flanigan MJ, et al.
`A whole(cid:173)genome assembly of Drosophila. Science 2000;287:2196(cid:173)204.
`10 Arabidopsis Genomics Initiative. Analysis of the genome sequence of the
`flowering plant Arabidopsis thaliana. Nature 2000;408:796(cid:173)815.
`11 Stein L. Genome annotation: from sequence to biology. Nat Rev Genet
`2001;2:493(cid:173)503.
`12 Subramanian G, Adams MD, Venter JC, Broder S. Implications of the
`human genome for understanding human biology and medicine. JAMA
`2001;286:2296(cid:173)306.
`13 Benton D. Bioinformatics—principles and potential of a new multidisci(cid:173)
`plinary tool. Trends Biotech 1996;14:261(cid:173)312.
`14 Maggio ET, Ramnarayan K. Recent developments in computational pro(cid:173)
`teomics. Trends Biotech 2001;19:266(cid:173)72.
`15 Burley SK, Almo SC, Bonanno JB, Capel M, Chance MR, Gaasterland T,
`et al. Structural genomics: beyond the human genome project. Nat Genet
`1999;23:151(cid:173)7.
`16 Tsoka S, Ouzounis CA. Recent developments and future directions in
`computational genomics. FEBS Lett 2000;480:42(cid:173)8.
`17 Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, et al.
`Activity of a specific inhibitor of the BCR(cid:173)ABL tyrosine kinase in the blast
`crisis of chronic myeloid leukemia and acute lymphoblastic leukemia
`with the Philadelphia chromosome. N Engl J Med 2001;344:1038(cid:173)42.
`18 Graeber TG, Eisenberg D. Bioinformatic identification of potential auto(cid:173)
`crine signaling loops in cancers from gene expression profiles. Nat Genet
`2001;29:295(cid:173)300.
`19 Debouk C, Metcalf B. The impact of genomics on drug discovery. Annu
`Rev Pharmacol Toxicol 2000;40:193(cid:173)208.
`20 Butler D. Are you ready for the revolution? Nature 2001;409:758(cid:173)60.
`
`When I use a word
`Meta(cid:173)
`
`Mr John Gleave, a neurosurgeon, has written to ask me
`the origin of the meta(cid:173) in meta(cid:173)analysis. The answer
`comes from Aristotle.
`The Greek preposition ♯♦♸♡´ (meta) had several
`meanings, depending on whether it governed the
`accusative, genitive, or dative case. With the accusative
`it could mean coming into or among, in pursuit of, or
`coming after in place or time; with the genitive it could
`mean in the midst of, between, or in common with;
`and with the dative it could mean in the company of or
`over and above. It was also used as a prefix to express
`such notions as sharing, being in the midst of,
`succession, pursuit, reversal, and (most commonly)
`change. Examples of the last include metabolism,
`metamorphosis, and metaplasia.
`In scientific English words its uses include
`“consequent upon” (as in the obsolete terms
`meta(cid:173)arthritic, metapneumonic), “behind” or “beyond”
`in an anatomical sense (metabranchial, metacarpal,
`metaphysis), “coming later” (metaphase, which comes
`after prophase), or “changing” (metachromasia, a
`property of materials that stain a different colour from
`the stain used). In geology meta(cid:173) is used to distinguish
`various types of metamorphic processes. And chemists
`use meta(cid:173) to differentiate certain metameric chemical
`compounds (such as metacresol, paracresol,
`orthocresol).
`And so to Aristotle. Some 250 years after his death,
`Aristotle’s manuscripts came into the hands of
`Andronicus of Rhodes, who edited them. Andronicus
`called one set of papers The Physics (♸♡` *♲♹♶♬♭♡´), dealing
`as they did with natural science. Then he published a
`set of papers that he called The Metaphysics (♸♡` ♯♦♸♡` ♸♡`
`*♲♹♶♬♭♡´), simply because it came after The Physics.
`However, because The Metaphysics dealt with what
`Aristotle called “primary philosophy,” or ontology,
`metaphysics came to be misunderstood as “the science
`of that which transcends the physical.”
`As a result, the prefix meta(cid:173) was then used to
`designate any higher science (actual or hypothetical)
`that dealt with more fundamental problems than the
`original science itself. This use first appeared in the
`
`1022
`
`early 17th century (John Donne, for example, writes
`about metatheology) but did not become really
`popular until the middle of the 19th century. Examples
`include metaethics (the study of the foundations of
`ethics, especially the nature of ethical statements) and
`metahistory (an inquiry into the principles that govern
`historical events).
`Then, from about 1940, it became commonplace to
`prefix meta(cid:173) to designate concern with basic principles.
`A metacriterion is a criterion that defines criteria. A
`metatheorem is a theorem about theorems. A
`metalanguage is a language that supplies terms for
`analysing a language; a metametalanguage does the
`same for a metalanguage. And Jean Tinguely described
`his machine(cid:173)like sculptures as “metamechanical.” (But
`a metaphysician is not a doctor’s doctor.)
`In these poststructuralist times we recognise many
`metaforms. Mantissa, a medical novel by John Fowles, is
`metafiction; Francois Truffaut’s film La Nuit Amercaine
`is metacinema; several paintings by Magritte, notably
`La Condition Humaine, are meta(cid:173)art; and John Cage’s
`piano piece 4’33’’ is metamusic.
`So meta(cid:173)analysis is an analysis of analyses, in which
`sets of previously published (or unpublished) data are
`themselves subjected as a whole to further analysis. In
`this statistical sense it was first used in the 1970s by GV
`Glass (Educ Res 1976;3(Nov):2). As he wrote, “The term
`is a bit grand, but it is precise and apt.” Incidentally,
`meta(cid:173)analysis should not be confused with metanalysis,
`which is the process whereby, for example, “a nadder”
`becomes “an adder” (see BMJ 1999;318:1758 and
`2000;321:953).
`I trust that this cures Mr Gleave’s metagrobolism.
`
`Jeff Aronson clinical pharmacologist, Oxford
`
`We welcome articles up to 600 words on topics such as
`A memorable patient, A paper that changed my practice, My
`most unfortunate mistake, or any other piece conveying
`instruction, pathos, or humour. If possible the article
`should be supplied on a disk. Permission is needed
`from the patient or a relative if an identifiable patient is
`referred to.
`
`Petitioner Microsoft Corporation - Ex. 1029, p. 1022
`
`BMJ VOLUME 324 27 APRIL 2002 bmj.com
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket